Selective Laser Trabeculoplasty for Open-Angle Glaucoma - Ophthalmology

More Info

---

Selective Laser Trabeculoplasty (SLT) is a relatively new and effective treatment option for open-angle glaucoma. It is designed to lower intraocular pressure (IOP) by improving the drainage of aqueous humor through the trabecular meshwork. In response to your questions, I will provide an overview of SLT, its effectiveness, and its comparison with other laser treatments, such as Argon Laser Trabeculoplasty (ALT).

1. Current Use of SLT in Taiwan: In Taiwan, many hospitals, including major institutions like National Taiwan University Hospital, have adopted SLT as a standard treatment for open-angle glaucoma. However, some facilities may still utilize ALT, which has been a traditional method for many years. The choice between SLT and ALT often depends on the specific circumstances of the patient and the equipment available at the facility.

2. Effectiveness of SLT: SLT has been shown to be effective in lowering IOP, with studies indicating a reduction of approximately 20-30% in many patients. It is particularly beneficial for those who are not adequately controlled on medications or who experience side effects from them. SLT is generally well-tolerated and can be repeated if necessary, making it a flexible option in managing glaucoma.

3. Comparison with ALT: While both SLT and ALT aim to lower IOP, there are some differences in their mechanisms and outcomes. SLT uses a lower energy level and is less likely to cause damage to surrounding tissues, which may result in fewer complications and a quicker recovery. ALT, on the other hand, may produce more immediate results but can also lead to more significant inflammation and scarring. Repeated treatments with ALT may be less effective over time due to the potential for increased scarring.

4. Safety and Repeatability: One of the advantages of SLT is its safety profile. It can be repeated multiple times if necessary, which is not always the case with ALT. Patients may require additional treatments if their IOP rises again after the initial procedure. The ability to repeat SLT without significant risks makes it a preferred option for many ophthalmologists.

5. Patient Suitability: SLT is generally suitable for patients with open-angle glaucoma who are either not responding well to medications or who prefer to avoid long-term medication use. It is also an option for those who have contraindications to traditional surgical procedures. However, it may not be as effective in patients with advanced glaucoma or those with significant structural damage to the optic nerve.

6. Overall Recommendations: If you are considering laser treatment for open-angle glaucoma, it is essential to discuss your specific situation with your ophthalmologist. They can provide personalized recommendations based on your eye health, IOP levels, and any previous treatments you may have undergone.
In conclusion, SLT is a promising option for managing open-angle glaucoma, offering a balance of effectiveness and safety. It is important to have a thorough discussion with your healthcare provider to determine the best treatment plan tailored to your needs. Regular follow-ups and monitoring are crucial in managing glaucoma effectively, regardless of the treatment chosen.